Best Practice & Research Clinical Gastroenterology
Volume 24, Issue 2 , Pages 91-97 , April 2010

Adverse effects of drugs on the esophagus

  • Radu Tutuian (Clinical Lead Outpatient Services and Gastrointestinal Function Laboratory)

      Affiliations

    • Corresponding Author InformationTel.: +41 31 632 2111; fax: +41 31 632 4861.

References 

  1. DeVault KR. Presbyesophagus: a reappraisal. Curr Gastroenterol Rep. 2002;4:193–199
  2. Dent J, Dodds WJ, Friedman RH, Sekiguchi T, Hogan WJ, Arndorfer RC, et al. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest. 1980;65:256–267
  3. Jaspersen D. Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management. Drug Saf. 2000;22:237–249
  4. Morris TJ, Davis TP. Doxycycline-induced esophageal ulceration in the U.S. Military service. Mil Med. 2000;165:316–319
  5. Kadayifci A, Gulsen MT, Koruk M, Savas MC. Doxycycline-induced pill esophagitis. Dis Esophagus. 2004;17:168–171
  6. Vãlean S, Petrescu M, Cãtinean A, Chira R, Mircea PA. Pill esophagitis. Rom J Gastroenterol. 2005;14:159–163
  7. de Groen PC, Lubbe DF, Hirsch LJ, Daifotis A, Stephenson W, Freedholm D, et al. Esophagitis associated with the use of alendronate. N Engl J Med. 1996;335:1016–1021
  8. González-Martín AJ, Calvo E, Bover I, Rubio MJ, Arcusa A, Casado A, et al. Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Espanol de Investigacion en Cancer de Ovario) study. Ann Oncol. 2005;16:749–755
  9. McDonnell AM, Lenz KL. Palifermin: role in the prevention of chemotherapy- and radiation-induced mucositis. Ann Pharmacother. 2007;41:86–94
  10. Pearlman M, Jendiroba D, Pagliaro L, Keyhani A, Liu B, Freireich EJ, et al. Dexrazoxane's protection of jejunal crypt cells in the jejunum of C3Hf/Kam mice from doxorubicin-induced toxicity. Cancer Chemother Pharmacol. 2003;52:477–481
  11. Law A, Kennedy T, Pellitteri P, Wood C, Christie D, Yumen O. Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2007;69:1361–1368
  12. Ypsilantis P, Tentes I, Assimakopoulos SF, Kortsaris A, Scopa CD, Simopoulos C. Mesna ameliorates intestinal mucosa damage after ifosfamide administration in the rabbit at a dose-related manner. J Surg Res. 2004;121:84–91
  13. Hensley ML, Hagerty KL, Kewalramani T, Green DM, Meropol NJ, Wasserman TH, et al. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. J Clin Oncol. 2009;27:127–145
  14. Yamaoka K, Takenawa H, Tajiri K, Yamane M, Kadowaki K, Marumo F, et al. A case of esophageal perforation due to a pill-induced ulcer successfully treated with conservative measures. Am J Gastroenterol. 1996;91:1044–1045
  15. Zografos GN, Georgiadou D, Thomas D, Kaltsas G, Digalakis M. Drug-induced esophagitis. Dis Esophagus. 2009 Apr 15;[Epub ahead of print]
  16. Tahan V, Sayrak H, Bayar N, Erer B, Tahan G, Dane F. Doxycycline-induced ulceration mimicking esophageal cancer. Cases J. 2008;1:144
  17. Stacher G, Schneider C, Steinringer H, Holzäpfel A, Gaupmann G, Stacher-Janotta G. Effects of 3-days' intake of a sustained-release preparation of the nitric oxide donor, isosorbide dinitrate, on oesophageal motility. Aliment Pharmacol Ther. 1997;11:967–971
  18. Aggestrup S, Jensen SL. Effects of pirenzepine and atropine on basal lower esophageal pressure and gastric acid secretion in man: a placebo-controlled randomized study. Dig Dis. 1991;9:360–364
  19. Corley DA, Levin TR, Habel LA, Buffler PA. Barrett's esophagus and medications that relax the lower esophageal sphincter. Am J Gastroenterol. 2006;101:937–944
  20. van Soest EM, Dieleman JP, Siersema PD, Schoof L, Sturkenboom MC, Kuipers EJ. Tricyclic antidepressants and the risk of reflux esophagitis. Am J Gastroenterol. 2007;102:1870–1877
  21. Lagergren J, Bergström R, Adami HO, Nyrén O. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med. 2000;133:165–175
  22. Tutuian R, Castell DO. Esophageal motility disorders (distal esophageal spasm, nutcracker esophagus, and hypertensive lower esophageal sphincter): modern management. Curr Treat Options Gastroenterol. 2006;9:283–294
  23. Kim HS, Conklin JL, Park H. The effect of sildenafil on segmental oesophageal motility and gastro-oesophageal reflux. Aliment Pharmacol Ther. 2006;24:1029–1036
  24. Broekaert D, Fischler B, Sifrim D, Janssens J, Tack J. Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2006;23:365–370
  25. Peghini PL, Katz PO, Castell DO. Imipramine decreases oesophageal pain perception in human male volunteers. Gut. 1998;42:807–813

PII: S1521-6918(10)00019-3

doi: 10.1016/j.bpg.2010.02.005

Best Practice & Research Clinical Gastroenterology
Volume 24, Issue 2 , Pages 91-97 , April 2010

Article Tools

* Image Usage & Resolution